A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Archives of Surgery

• Publication date

  1987-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHSURG.1987.01400220030004PMID 3310962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infectious complications in liver transplantation.

  1988cited by this paper
• A RANDOMIZED CLINICAL TRIAL COMPARING OKT3 AND STEROIDS FOR TREATMENT OF HEPATIC ALLOGRAFT REJECTION

  1987cited by this paper
• Histologic response to OKT3 therapy for hepatic allograft rejection.

  1987cited by this paper
• Pediatric liver transplantation at UCLA.

  1987cited by this paper
• ORTHOCLONE OKT3 in Treatment of Allografts Rejected Under Cyclosporine-Steroid Therapy.

  1986cited by this paper
• Structure and function of the T cell receptor/T3 complex.

  1985cited by this paper
• A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.

  1985cited by this paper
• Reversal of acute allograft rejection with monoclonal antibody

  1985cited by this paper
• Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.

  1981cited by this paper
• Monoclonal antibodies defining distinctive human T cell surface antigens.

  1979cited by this paper

• Management of long-term complications from immunosuppression

  2024cites this paper
• Immunomodulatory Activity of Ethanolic Extract of Propolis (Apismellifera Linn) on Cyclophosphamide Treated Immunosuppressed Rats

  2017cites this paper
• Immunology of Liver Transplantation

  2016cites this paper
• Chapter 92 – Special Considerations for Immunosuppression in Children

  2015cites this paper
• Current status of immunosuppression in liver transplantation.

  2013cites this paper
• the OKT3 monoclonal antibody Monocyte procoagulant activity induced by in vivo administration of

  2011cites this paper
• Solid Organ Transplantation

  2011cites this paper
• Antibody immunosuppressive therapy in solid organ transplant

  2010cites this paper
• Antibody immunosuppressive therapy in solid-organ transplant: Part I.

  2010cites this paper
• Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts

  2010cites this paper
• Liver transplant: a primer.

  2010cites this paper
• Antibody immunosuppressive therapy in solid-organ transplant

  2010cites this paper
• Overview of immunosuppression in liver transplantation.

  2009cites this paper
• Capítulo 19 – Rechazo agudo

  2008cites this paper
• Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction

  2008cites this paper
• 76 – Special Considerations for Pediatric Immunosuppression After Liver Transplantation

  2005cites this paper
• Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation

  2005cites this paper
• Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

  2005cites this paper
• Monoclonal antibody-based strategies in autoimmunity and transplantation.

  2005cites this paper
• Analysis of Long-term Outcomes of 3200 Liver Transplantations Over Two Decades: A Single-Center Experience

  2005cites this paper
• Therapy for Acute Rejection in Pediatric Organ Transplant Recipients

  2003cites this paper
• Adoptive Immunotherapy

  2003cites this paper
• Polyclonal and Monoclonal Antibodies

  2001cites this paper
• Monoclonal Antibody Targeting of the T Cell Receptor Complex

  2001cites this paper
• Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitro

  2001cites this paper
• Modern immunosuppression.

  2000cites this paper
• PHASE I TRIAL OF HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM LIVING DONORS1

  2000cites this paper
• Use of antilymphocyte induction therapy in liver transplantation.

  1999cites this paper
• [Follow-up of liver transplantation].

  1999cites this paper
• A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees.

  1999cites this paper
• Treatment of liver allograft rejection.

  1999cites this paper
• A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection

  1997cites this paper
• Signes et traitement du rejet en transplantation hépatique

  1997cites this paper
• OKT3 escalating dose regimens provide effective therapy for renal allograft rejection

  1996cites this paper
• Monocyte procoagulant activity induced by in vivo administration of the OKT3 monoclonal antibody.

  1996cites this paper
• Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.

  1996cites this paper
• Ten years of Orthoclone OKT3 (muromonab-CD3): a review.

  1996cites this paper
• Ten Years of Orthoclone OKT3 (Muromonab-CD3): A Review

  1996cites this paper
• Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients.

  1995cites this paper
• The Treatment of Intractable Rejection with Tacrolimus (FK506) in Pediatric Liver Transplant Recipients

  1995cites this paper
• OKT3 monoclonal antibody treatment of steroid-resistant liver transplant rejection

  1994cites this paper
• Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.

  1994cites this paper
• The manipulation of cellular immunity by monoclonal antibodies in cancer patients.

  1994cites this paper
• FK 506 rescue therapy for intractable liver allograft rejection

  1994cites this paper
• Primary care management of the liver transplant patient.

  1994cites this paper
• Liver transplantation in children.

  1994cites this paper
• Use of Monoclonal Antibodies in Corneal Transplantation

  1994cites this paper
• OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients.

  1994cites this paper
• Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment.

  1993cites this paper
• Transplant rejection. Mechanisms and treatment.

  1993cites this paper
• Anti-OKT3 response following prophylactic treatment in paediatric kidney transplant recipients

  1993cites this paper
• Adverse events associated with OKT3 immunosuppression in the prevention or treatment of allograft rejection

  1993cites this paper
• OKT3 rescue for steroid-resistant rejection in adult liver transplantation.

  1993cites this paper
• Treatment and prevention of liver allograft rejection with OKT3

  1993influential citation
• Selective immunosuppression with anti-T cell monoclonal antibodies.

  1992cites this paper
• Anti-T-Cell Monoclonal Antibodies as Immunosuppressive Agents

  1992cites this paper
• [Hepatic allograft rejection. Diagnostic and therapeutic aspects].

  1992cites this paper
• Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.

  1992cites this paper
• Role of maintenance immunosuppression and methylprednisolone in OKT3-induced cytokine release.

  1992cites this paper
• A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy.

  1992cites this paper
• Treatment of Acute Rejection

  1992cites this paper
• OKT3 Treatment of Steroid‐Resistant Rejection in Pediatric Liver Transplant Recipients

  1992cites this paper
• Liver allograft rejection: analysis of OKT3 rescue therapy.

  1992cites this paper
• Liver retransplantation--indications, frequency, results.

  1992cites this paper
• OKT3 THERAPY FOR HEPATIC ALLOGRAFT REJECTION: DIFFERENTIAL RESPONSE IN ADULTS AND CHILDREN

  1991cites this paper
• Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.

  1991cites this paper
• OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.

  1991cites this paper
• Muromonab CD‐3: A Review of Its Pharmacology, Pharmacokinetics, and Clinical Use in Transplantation

  1991cites this paper
• [Rejection in liver transplantation].

  1991cites this paper
• Pediatric Liver Transplantation

  1991cites this paper
• OKT3 prophylaxis in liver transplantation

  1991cites this paper
• Aseptic meningitis and muromonab-CD3 therapy.

  1991cites this paper
• Drug Information Analysis Service

  1991cites this paper
• Immunological monitoring during and following OKT3 therapy in children

  1991cites this paper
• Use of monoclonal antibody immunosuppressive therapy in pediatric renal and liver transplantation

  1991cites this paper
• Perioperative Management of the Liver Transplant Patient

  1990cites this paper
• The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation.

  1990cites this paper
• The successful use of repeated courses of OKT3 for hepatic allograft rejection using %T3 cells to adjust dose.

  1989cites this paper
• Postoperative Care After Liver Transplantation

  1989cites this paper
• The first 100 liver transplantations at the Mayo Clinic.

  1989cites this paper
• Liver transplantation therapy for children: Part 2.

  1988cites this paper
• The importance of percutaneous liver biopsy in the management of the liver transplant recipient.

  1988cites this paper
• Radionuclide evaluation of liver transplants.

  1988cites this paper